AC
STIM icon

AXQ Capital’s Neuronetics STIM Stock Holding History

AXQ Capital’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.3K Sell
11,024
-1,284
-10% -$1.87K ﹤0.01% 960
2026
Q1 		$17.8K Buy
+12,308
New +$19.5K ﹤0.01% 967
2025
Q4 		– Sell
-45,284
Closed -$124K – 922
2025
Q3 		$124K Buy
+45,284
New +$161K 0.05% 500

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AXQ Capital's STIM Position: Q2 2026 in Review

AXQ Capital reduced its Neuronetics (STIM) stake by 10% in Q2 2026, selling an estimated $1.87K and leaving 11,024 shares worth $14.3K. The position accounts for ﹤0.01% of the portfolio, ranked #960.

AXQ Capital first reported a position in STIM in Q3 2025 and has held it in 3 quarters since. The position peaked at $124K in Q3 2025. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • AXQ Capital held 11,024 shares of Neuronetics worth $14.3K as of Q2 2026.
  • AXQ Capital sold 1,284 Neuronetics shares in Q2 2026, an estimated $1.87K.
  • Neuronetics made up ﹤0.01% of AXQ Capital's portfolio in Q2 2026, its #960 holding.
  • AXQ Capital first reported a position in Neuronetics in Q3 2025 and has held it in 3 quarters since.
  • AXQ Capital's Neuronetics position peaked at $124K in Q3 2025.
  • 87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.